Analyst Reco. BioNTech SE BOERSE MUENCHEN

Equities

Real-time BOERSE MUENCHEN Other stock markets 02:00:20 2024-05-28 EDT			5-day change	1st Jan Change
90.65 ^EUR	+0.72%		+7.02%	-5.40%

05-24	European Equities Traded in the US as American Depositary Receipts Trend Higher Friday, End Week Marginally Lower	MT
05-24	BIONTECH : Deutsche Bank remains Neutral	ZD

BIONTECH : Deutsche Bank remains Neutral	05-24	ZD
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	05-17	MT
Evercore ISI Starts BioNTech With In Line Rating, $100 Price Target	05-14	MT
BIONTECH : UBS remains Neutral	05-10	ZD
HC Wainwright Raises BioNTech SE Price Target to $113 From $107, Maintains Buy Rating	05-08	MT
BIONTECH : Deutsche Bank reaffirms its Neutral rating	05-08	ZD
TD Cowen Adjusts BioNTech Price Target to $98 From $95, Maintains Hold Rating	05-07	MT
BMO Capital Adjusts BioNTech Price Target to $122 From $123, Maintains Outperform Rating	05-07	MT
BIONTECH : Goldman Sachs reiterates its Neutral rating	05-07	ZD
BIONTECH : Jefferies gives a Neutral rating	05-06	ZD
BIONTECH : Gets a Neutral rating from Deutsche Bank	04-23	ZD
UBS Cuts BioNTech Price Target to $101 From $110, Maintains Neutral Rating	03-27	MT
BIONTECH : Deutsche Bank remains Neutral	03-22	ZD
TD Cowen Adjusts BioNTech Price Target to $95 From $101, Maintains Market Perform Rating	03-21	MT
BIONTECH : A miss is a miss	03-21
BIONTECH : Deutsche Bank reaffirms its Neutral rating	03-21	ZD
BIONTECH : Goldman Sachs reiterates its Neutral rating	03-21	ZD
BIONTECH : Jefferies sticks Neutral	03-20	ZD
BIONTECH : UBS gives a Neutral rating	03-20	ZD
BMO Capital Initiates Coverage on BioNTech With Outperform Rating, $127 Price Target	02-23	MT

No results for this search

BIONTECH : A miss is a miss

March 21, 2024 at 09:27 am